Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 390 participants.

Also called NCT01878669

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 390 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01878669
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Türkiye (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT01878669. Randomized; triple masking; primary purpose prevention. Start 2013-01 (registry gives no type); primary completion 2017-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention
Acronym
EASE-PCI
Intervention (Drug)
N-acetyl cysteine
Intervention (Drug)
Saline
Lead sponsor
Suleyman Demirel University (class: other)

Record details

Record id
cardio:ct-nct01878669
Content hash
d8dbefe2646267c740d40aa57873306e2dbb86c34a8f581a487efac73da99ac9